News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MEDA: Collaboration with Omega Pharma NV (0OMEP.BR) for SB12



12/9/2011 11:44:59 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

Meda (STO:MEDAA) has signed a 5-year collaboration agreement with Omega Pharma for SB12 in France, Italy, Belgium and Greece. Omega Pharma is a Belgian company with a leading market position in the OTC segment in these countries.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES